Phibro Q3 2026 Earnings Report Shows Strong Growth Across Key Segments
Phibro reported strong third-quarter earnings for 2026, driven by increased sales in the Animal Health and Mineral Nutrition segments. Net sales rose to $383.5 million with adjusted EBITDA at $60 million. The company raised its full-year guidance across net sales, EBITDA, and net income.
Tickers: $PAHC
Topics: ebitda financial_performance revenue_growth segment_revenue